Mechanisms
and
Therapeutic
Implications"
is
an
exemplary
piece
of
scientific
literature,
masterfully
written
deeply
insightful.The
comprehensive
analysis
eloquent
presentation
the
complex
mechanisms
ferroptosis
its
implications
in
pathology
Inflammatory
Bowel
Disease
showcase
author's
profound
understanding
extensive
research
field.The
meticulous
detail,
clear
articulation,
groundbreaking
revelations
provide
invaluable
contribution
to
medical
science,
particularly
context
gastrointestinal
disorders.The
integration
current
with
thoughtful
discussion
on
potential
therapeutic
targets
brilliantly
executed,
reflecting
cutting-edge
developments
cellular
biology
their
applications
improving
patient
outcomes.This
article
not
only
a
testament
expertise
but
also
beacon
knowledge
for
researchers,
clinicians,
academicians
alike,
paving
way
innovative
treatments
better
IBD.It
outstanding
work
that
deserves
highest
praise
widespread
recognition
significant
impact
community
beyond.
Journal of Cancer,
Journal Year:
2024,
Volume and Issue:
15(7), P. 2024 - 2032
Published: Jan. 1, 2024
Objective:
This
study
evaluated
the
efficacy
and
safety
of
gemcitabine
oxaliplatin
intrathoracic
perfusion
chemotherapy
(IPCGOR)
regimen
combined
with
interleukin-2
(IL-2)
for
advanced
non-small
cell
lung
cancer
(NSCLC).Methods:
We
conducted
a
retrospective
analysis
460
NSCLC
patients
from
Yunnan
Province
Early
Cancer
Diagnosis
Treatment
Project
(June
2020-October
2022),
assessing
IPCGOR
IL-2
combination.Outcomes
were
measured
based
on
RECIST
1.1
criteria,
focusing
objective
response
rate
(ORR),
disease
control
(DCR),
median
progression-free
survival
(mPFS),
overall
(MOS),
treatment
safety.Results:
The
demonstrated
an
ORR
67.4%,
DCR
97.4%,
mPFS
8.5
months,
MOS
12.5
months.14
underwent
successful
surgery
post-treatment.Common
adverse
reactions
manageable,
no
treatment-related
deaths
reported.
Conclusion:The
shows
promising
tolerable
profile
NSCLC.These
findings
suggest
its
potential
as
reference
treating
NSCLC.However,
study's
nature
single-center
design
pose
limitations.Future
research
should
focus
prospective
studies,
randomized
controlled
trials,
long-term
outcome
assessments,
particularly
in
diverse
patient
subgroups,
to
further
validate
refine
clinical
application
this
regimen.
Frontiers in Pharmacology,
Journal Year:
2023,
Volume and Issue:
14
Published: Nov. 6, 2023
Abnormal
cellular
apoptosis
plays
a
pivotal
role
in
the
pathogenesis
of
Multiple
Myeloma
(MM).
Over
years,
BCL-2,
crucial
anti-apoptotic
protein,
has
garnered
significant
attention
MM
therapeutic
research.
Venetoclax
(VTC),
small-molecule
targeted
agent,
effectively
inhibits
promoting
programmed
death
cancerous
cells.
While
VTC
been
employed
to
treat
various
hematological
malignancies,
its
particular
efficacy
showcased
potential
for
broader
clinical
applications.
In
this
review,
we
delve
into
intricacies
how
modulates
cells
by
targeting
BCL-2
and
overarching
influence
protein
family
regulation.
Our
findings
highlight
nuanced
interplay
between
VTC,
MM,
offering
insights
that
may
pave
way
optimizing
strategies.
Through
comprehensive
analysis,
aim
lay
solid
groundwork
future
explorations
VTC’s
applications
profound
effects
on
apoptosis.
Frontiers in Endocrinology,
Journal Year:
2023,
Volume and Issue:
14
Published: Dec. 15, 2023
To
compare
the
therapeutic
effects
and
adverse
reactions
of
sterilizing
rare
earth
carbonate
combined
with
concurrent
chemoradiotherapy
simple
in
treatment
late-stage
non-small
cell
lung
cancer
(NSCLC),
to
analyze
reasons
for
differences.
A
total
817
patients
pathologically
diagnosed
NSCLC
from
June
1,
2021
December
30,
2022,
affiliated
hospital
Kunming
University
Science
Technology,
were
selected.
They
randomly
divided
into
a
control
group
394
people
an
experimental
423
people.
The
was
given
(cisplatin
+
etoposide),
while
simultaneously
took
low
dose
sterilized
(0.05mg/Kg).
χ²
test
Fisher's
used
clinical
pathological
features,
objective
response
rate
(ORR),
ECOG
score,
two
groups
patients,
survival
analysis
progression-free
(PFS)
groups.
Cox
regression
factors
related
prognosis.
differences
features
between
not
statistically
significant,
all
P>0.05.
ORR
45.18%
(178/394),
89.83%
(380/423),
significant
difference
(P=0.001).
After
treatment,
score
lower
than
that
group,
P<0.001.
reaction
grading
both
below
level
3
after
no
treatment-related
fatalities
occurred.
risk
pulmonary
infection
bone
marrow
suppression
group.
In
compared
chemoradiotherapy,
combination
can
significantly
improve
short-term
effect
prognosis
good
safety.
The Journal of Gene Medicine,
Journal Year:
2024,
Volume and Issue:
26(2)
Published: Feb. 1, 2024
Abstract
Background
Colorectal
cancer
(CRC)
poses
a
significant
health
challenge.
This
study
aims
to
investigate
the
prognostic
value
of
regulatory
T
cell
(Treg)‐related
gene
signature
in
CRC.
Methods
We
extracted
expression
and
clinical
data
on
CRC
from
The
Cancer
Genome
Atlas
(TCGA)
Gene
Expression
Omnibus
(GEO)
databases.
module
related
Treg
was
identified
by
weighted
co‐expression
network
analysis
(WGCNA).
genes
were
filtered
univariate
Cox,
least
absolute
shrinkage
selection
operator
(LASSO)
multivariate
Cox
regression
analysis.
A
riskscore
model
established
terms
key
Treg‐related
genes.
reliability
this
validated
using
external
GEO
dataset.
association
with
features,
mutation
patterns
signaling
pathways
explored.
Results
Genes
blue
showed
strongest
Tregs.
After
series
filtering
cycles,
seven
genes,
GDE1,
GSR,
HSPB1,
AOC2,
TBX19,
TAMM41
TIGD6,
selected
construct
model.
performed
well
evaluating
patients’
survival
TCGA
cohort,
further
affirmed
GSE17536
validation
cohort.
For
precise
evaluation
survival,
we
nomogram
light
factors.
Patients
different
risk
groups
had
distinct
pathway
activities.
five
significantly
associated
infiltration
samples.
Conclusion
useful
may
contribute
prognosis
evaluation,
direct
tailored
treatment,
hopefully
improve
outcomes
patients.
Heliyon,
Journal Year:
2024,
Volume and Issue:
10(7), P. e29273 - e29273
Published: April 1, 2024
BackgroundOesophageal
squamous
cell
carcinoma
(ESCC)
is
a
leading
cause
of
cancer-related
deaths
worldwide
because
existing
treatments
are
often
insufficient.
Therefore,
new,
reliable
biomarkers
must
be
identified.
CTSL
overexpression
closely
associated
with
tumour
progression
and
poor
prognosis.
However,
the
role
mechanism
as
an
oncogene
in
ESCC
remain
unclear.MethodsGenome-wide
association
study
(GWAS)
data
were
used
for
Mendelian
randomization
analysis
to
investigate
possible
relationships
between
ESCC.
The
correlation
expression
prognosis
was
analysed
using
GEO,
TCGA,
GEPIA
data.
We
compared
among
types
single-cell
sequencing.
Correlations
microenvironment,
immune
infiltration,
mutational
load,
immunological
checkpoints,
treatment
sensitivity
patients
investigated.
Finally,
mouse
models
cellular
investigations,
we
assessed
effects
on
growth,
apoptosis,
metastasis
cells.ResultsCTSL
overexpressed
correlated
also
discovered
its
close
immunity,
especially
tumour-associated
macrophages
checkpoints
microenvironment.
may
play
key
development
by
affecting
M2
macrophage
polarisation.
marker
genes
showed
significant
positive
correlations.
confirmed
relationship
our
vitro
vivo
experiments
demonstrated
that
promoted
proliferation
migration
cells,
validating
bioinformatic
analysis.ConclusionCTSL
emerged
crucial
gene
influences
patient
particularly
macrophages.
targeting
or
modulating
levels
provide
new
therapeutic
strategies
Journal of Biochemical and Molecular Toxicology,
Journal Year:
2025,
Volume and Issue:
39(1)
Published: Jan. 1, 2025
ABSTRACT
The
eye
is
considered
to
be
an
immune‐privileged
region.
However,
several
parts
of
the
have
distinct
mechanisms
for
delivering
immune
cells
injury
sites
or
even
in
response
aging.
Although
these
responses
are
intended
protective,
visual
acuity
can
compromised
by
release
pro‐inflammatory
cytokines
cells,
which
induce
chronic
inflammation
and
fibrosis.
Age‐related
diseases
(AREDs)
primary
cause
vision
impairment
(VI)
elderly,
with
a
poor
comprehension
their
pathophysiology.
affect
both
anterior
posterior
segments,
resulting
diminished
quality
life
risk
irreversible
blindness.
Immune
system
dysregulation
upregulation
been
linked
AREDs,
underscoring
need
comprehend
inflammation's
impact
on
ocular
disorders
enhance
patient
symptom
management.
In
this
framework,
PubMed
database
was
searched
using
medical
subject
headings
(MeSH)
terms
“Age‐related
diseases,”
“dry
syndrome,”
“glaucoma,”
“cataract,”
“diabetic
retinopathy,”
“inflammation,”
“interleukin,”
“cytokine”
aim
overview
role
AREDs
discuss
potential
therapeutic
approaches.
Frontiers in Neuroscience,
Journal Year:
2025,
Volume and Issue:
18
Published: Jan. 15, 2025
Intracerebral
hemorrhage
(ICH)
is
a
major
public
health
challenge
worldwide,
and
associated
with
elevated
rates
of
mortality,
disability,
morbidity,
especially
in
low-
middle-income
nations.
However,
our
knowledge
the
detailed
molecular
processes
involved
ICH
remains
insufficient,
particularly
those
secondary
injury
stage,
resulting
lack
effective
treatments
for
ICH.
Human
platelet
lysates
(HPL)
are
abundant
bioactive
factors,
numerous
studies
have
demonstrated
their
beneficial
effects
on
neurological
diseases,
including
anti-neuroinflammatory
ability,
anti-oxidant
effects,
maintenance
blood-brain
barrier
integrity,
promotion
neurogenesis.
In
this
review,
we
thoroughly
explore
potential
HPL
treating
from
three
critical
perspectives:
rationale
selecting
as
treatment
ICH,
mechanisms
through
which
contributes
to
management,
additional
measures
necessary
We
elucidate
role
platelets
pathophysiology
highlight
limitations
current
options
advancements
preclinical
research
application
disorders.
Furthermore,
historical
developments
preparation
methods
field
biomedicine
discussed.
Additionally,
summarize
molecules
present
therapeutic
Finally,
outline
issues
that
must
be
addressed
regarding
utilizing
modality
Objective:
This
study
investigates
the
development
trends
and
research
hotspots
in
clinical
testing
for
multiple
myeloma
from
2000
to
2023,
using
bibliometric
techniques.
Method:
Search
relevant
literature
on
of
published
Web
Science
Core
Collection
(WoSCC)
use
CiteSpace
6.2.R4
software
draw
a
visual
knowledge
map
authors,
institutions,
national
regional
cooperation
networks,
journals,
keywords,
conduct
analysis.
Results:
The
found
an
upward
trend
publications
over
specified
period,
with
significant
growth
noted
2012
onwards.
majority
originates
United
States,
contributions
institutions
like
Mayo
Clinic
MD
Anderson
Cancer
Center.
Analysis
author
collaboration
networks
indicated
relatively
low
centrality,
suggesting
minimal
among
researchers.
Bibliometric
mapping
highlighted
several
field
including
therapeutic
strategies
involving
proteasome
inhibitors
immunomodulatory
drugs,
role
stem
cell
transplantation,
importance
achieving
monitoring
residual
disease.
Conclusion:
is
characterized
by
growing
body
research,
States.
Despite
increasing
volume
there
need
enhanced
researchers
consolidate
findings
advance
practice.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
15
Published: Jan. 17, 2025
Our
previous
research
highlighted
the
potential
role
of
immunoglobulin
G4
(IgG4)
in
mediating
immunosuppression
within
tumor
microenvironment
(TME).
Tertiary
lymphoid
structures
(TLS)
TME
have
important
immune-related
functions.
This
study
aims
to
analyze
distribution
characteristics
IgG4-expressing
cells,
regulatory
T
cells
(Tregs),
and
M2-type
macrophages
as
well
elucidate
relationship
between
IgG4
polarization
M2
TLS
esophageal
cancer.
To
IgG4,
Treg
assess
impact
on
macrophage
polarization.
Esophageal
cancer
tissue
were
analyzed
with
multiplex
immunofluorescence
determine
spatial
density
B
their
subtypes.
The
CD8+
TLS,
along
interleukin-10
(IL-10)
expression
presence,
was
studied.
Serum
IL-10
levels
compared
patients
healthy
controls.
In
vitro,
monocyte
differentiation
into
observed.
inversely
related
mature
indicating
a
immunosuppressive
(P<0.05,*).
analysis
revealed
that
both
(P<0.01,
**)
(P<0.0001,
****)
significantly
elevated
positively
correlated
controls
**).
vitro
experiments
confirmed
macrophages,
potentially
enhancing
phenotype
TLS.
may
contribute
by
promoting
which
could
be
therapeutic
target.